StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report released on Monday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
AMPE stock opened at $0.00 on Monday. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $1.05. The firm has a market cap of $681.00, a PE ratio of 0.00 and a beta of 3.77.
About Ampio Pharmaceuticals
Featured Stories
- Five stocks we like better than Ampio Pharmaceuticals
- What is the Australian Securities Exchange (ASX)
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- What is the NASDAQ Stock Exchange?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- What is a Low P/E Ratio and What Does it Tell Investors?
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
